Akuzawa N, Obinata H, Izumi T et al (2007) Morphine is an exogenous ligand for MrgX2, a G-protein coupled receptor for cortistatin. J Cell Anim Biol 2:4–9
Ali H (2017) Emerging roles for MAS-related G protein-coupled receptor-X2 in host defence peptide, opioid, and neuropeptide-mediated inflammatory reactions. Adv Immunol 136:123–162. https://doi.org/10.1016/bs.ai.2017.06.002
Alkanfari I, Gupta K, Jahan T et al (2018) Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, hemokinin-1, human β-defensin-3, and icatibant. J Immunol 201:343–349. https://doi.org/10.4049/jimmunol.170179324
Allen JA, Roth BL (2011) Strategies to discover unexpected targets for drugs active at G protein coupled receptors. Annu Rev Pharmacol Toxicol 51:117–144. https://doi.org/10.1146/annurev-pharmtox-010510-100553
Allen JW, Horais KA, Tozier NA (2006) Opiate pharmacology of intrathecal granulomas. Anesthesiology 105:590–598. https://doi.org/10.1097/00000542-200609000-00025
Aronson JK (2016). In: Aronson JK (ed) Meyler’s side effects of drugs, 16th edn. Elsevier, Oxford, pp 1111–1127
Ayudhya CCN, Roy S, Alkanfari, et al (2019) Identification of gain and loss of function missense variants in MRGPRX2’s transmembrane and intracellular domains for mast cell activation by substance P. Int J Mol Sci 20:5247. https://doi.org/10.3390/ijms20215247
Ayudhya CCN, Amponnawarat a, Roy S, et al (2021) MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants. Cells 10:156. https://doi.org/10.3390/cells10010156
Babina M (2020) The pseudo-allergic/neurogenic route of mast cell activation via MRGPRX2: discovery, functional programs, regulation, relevance to disease, and relation with allergic stimulation. Itch 5(2):e32. https://doi.org/10.1097/itx.0000000000000032
Babina M, Wang Z, Roy S et al (2021) MRGPRX2 is the codeine receptor of human skin mast cells: desensitization through β-arrestin and lack of correlation with the FcεRI pathway. J Invest Dermatol 141:1286–96.e4. https://doi.org/10.1016/j.jid.2020.09.01
Babina M, Wang Z, Li Z et al (2022) FcERI- and MRGPRX2-evoked acute degranulation responses are fully additive in human skin mast cells. Allergy 77:1906–1909. https://doi.org/10.1111/all.15270
Bahri R, Custovic A, Korosec P et al (2018) Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol 142:485–496. https://doi.org/10.1016/j.jaci.2018.01.043
Baldo BA (2021) Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin syndrome. Arch Toxicol 95:2627–2642. https://doi.org/10.1007/s00204-021-03068-2
Baldo BA, Fisher MM (1983) Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 20:1393–1400. https://doi.org/10.1016/0161-5890(83)90171-2
Baldo BA, Pham NH (1994) Structure-activity studies on drug-induced anaphylactic reactions. Chem Res Toxicol 7:703–721. https://doi.org/10.1021/tx00042a001
Baldo BA, Pham NH (2012) Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care 40:216–235. https://doi.org/10.1177/0310057X1204000204
Baldo BA, Pham NH (2021) Drug allergy: clinical aspects, diagnosis, mechanisms structure-activity relationships, 2nd edn. Springer Nature, Cham, pp 3–8 (74-80, 324-354, 418–433). https://doi.org/10.1007/978-3-030-51740-3
Baldo BA, Fisher MM, Pham NH (2009) On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 39:325–344. https://doi.org/10.1111/j.1365-2222.2008.03171.x
Ballantyne JC, Loach AB, Carr DB (1988) Itching after epidural and spinal opiates. Pain 33:149–160. https://doi.org/10.1016/0304-3959(88)90085-1
Barke KE, Hough LB (1993) Opiates, mast cells and histamine release. Life Sci 53:1391–1399. https://doi.org/10.1016/0024-3205(93)90581-m
Barnea G, Strapps W, Herrada G et al (2008) The genetic design of signaling cascades to record receptor activation. Proc Nat Acad Sci 105:64–69. https://doi.org/10.1073/pnas.0710487105
Barth H, Giertz H, Schmal A et al (1987) Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol. Agents and Actions 20:310–313. https://doi.org/10.1007/BF02074699
Blunk JA, Schmelz M, Zeck S et al (2004) Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 98:364–370. https://doi.org/10.1213/01.ANE.0000097168.32472.0D
Bowdle TA, Even A, Shen DD (2004) Methadone for the induction of anesthesia: plasma histamine concentration, arterial blood pressure, and heart rate. Anesth Analg 98:1692–1697. https://doi.org/10.1213/01.ANE.0000114085.20751.20
Brashear RE, Kelly MT, White AC (1974) Elevated plasma histamine after heroin and morphine. J Lab Clin Med 83:451–457
Casale TB, Bowman S, Kaliner M (1984) Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 73:775–781. https://doi.org/10.1016/0091-6749(84)90447-0
Coombs RRA, Gell PGH (1968) Classification of allergic reactions responsible for drug hypersensitivity reactions. In: Coombs RRA, Gell PGH (eds) Clinical aspects of immunology, 2nd edn. Davis, Philadelphia, pp 575–596
Cop N, Decuyper II, Faber MA et al (2017) Phenotypic and functional characterization of in vitro cultured human mast cells. Cytom B Clin Cytom 92:348–354. https://doi.org/10.1002/cyto.b.21399
Cop N, Ebo DG, Bridts CH et al (2018) Influence of IL-6, IL-33, and TNF-alpha on human mast cell activation: lessons from single cell analysis by flow cytometry. Cytom B Clin Cytom 94:405–411. https://doi.org/10.1002/cyto.b.21547
Crabbe Erush S (1996) Narcotic Allergy. P&T 21:250–252,292
Decuyper II, Ebo DG, Uyttebroek AP et al (2016) Quantification of specific IgE antibodies in immediate drug hypersensitivity: more shortcomings than potentials? Clin Chim Acta 460:184–189. https://doi.org/10.1016/j.cca.2016.06.043
Decuyper II, Mangodt EA, Van Gasse AL et al (2017) In vitro diagnosis of immediate drug hypersensitivity anno 2017: potentials and limitations. Drugs R&D 17:265–278. https://doi.org/10.1007/s40268-017-0176-x
Easton MP, Bailey PL (2001) Cardiovascular pharmacology of anesthetics. In: Estafanous FG, Barash PG, Reves JG (eds) Cardiac anesthesia: principles and practice. Lipincott Williams & Wilkins, Philadelphia, pp 295–318
Ebo DG, Van der Poorten M-L, Elst J et al (2021) Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity. Br J Anaesth 126:e27–e29. https://doi.org/10.1016/j.bja.2020.10.006
Elst J, Sabato V, Faber MA (2020a) RNA Silencing: a model to explore the MRGPRX2-pathway in cultured human mast cells. J Allergy Clin Immunol 145(AB249):Abst809. https://doi.org/10.1016/j.jaci.2019.12.104
Elst J, Sabato V, Hagendorens MM et al (2020b) Measurement and functional analysis of the mas-related G protein-coupled receptor MRGPRX2 on human mast cells and basophils. In: Gibbs BF, Falcone FH (eds) Basophils and Mast cells: methods and protocols, methods in molecular biology, vol 2163. Springer Science+Business Media, New York, pp 219–226. https://doi.org/10.1007/978-1-0716-0696-4_18
Elst J, van der Poorten MM, Faber MA et al (2020c) Mast cell activation tests: a proof of concept. Br J Anaesth 125:970–975. https://doi.org/10.1016/j.bja.2020.06.024
Elst J, Sabato V, Faber MA et al (2021) MRGPRX2 and immediate drug hypersensitivity: insights from cultured human mast cells. J Investig Allergol Clin Immunol 31:489–499. https://doi.org/10.18176/jiaci.0557
Elst J, van der Poorten M-LM, Van Gasse AL et al (2022) Tryptase release does not discriminate between IgE- and MRGPRX2-mediated activation in human mast cells. Clin Exp Allergy 52:797–800. https://doi.org/10.1111/cea.14110
Ennis M, Schneider C, Nehring E, et al (1991) Histamine release induced by opioid analgesics: a comparative study using porcine mast cells. Agents and Actions 33(20):2. https://doi.org/10.1007/BF01993116
Evans AGJ, Nasmyth A, Stewart HC (1952) The fall of blood pressure caused by intravenous morphine in the rat and the cat. Br J Pharmacol Chemother 7:542–552. https://doi.org/10.1111/j.1476-5381.1952.tb00720.x
Falcone FH, Wan D, Barwary N et al (2018) RBL cells as models for in vitro studies of mast cells and basophils. Immunol Rev 282:47–57. https://doi.org/10.1111/imr.12628
Feldberg W, Paton WDM (1951) Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators. J Physiol 114:490–509. https://doi.org/10.1113/jphysiol.1951.sp004639
Fisher MM, Baldo BA (2000) Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 28:167–170. https://doi.org/10.1177/0310057X0002800207
Fisher MM, Harle DG, Baldo BA (1991) Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 9:309–318. https://doi.org/10.1007/BF02802310
留言 (0)